Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Sea 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place To Work
Tech
Tech
Ai
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-suite
Ceo Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Johnson & Johnson
Johnson & Johnson
Page 11 of 18
Health
Why Europe’s summer COVID vaccination target could still be on track
By
David Meyer
February 1, 2021
Magazine
The companies business leaders admire the most—and are watching closely
By
Matthew Heimer
and
Scott DeCarlo
February 1, 2021
Politics
Johnson & Johnson’s single-dose COVID-19 vaccine is 66% effective, lagging rivals
By
The Associated Press
January 29, 2021
Newsletters
Stocks to watch under a Biden presidency
By
Bernhard Warner
January 26, 2021
Newsletters
Last week’s vaccine-led rally was one for the record books—but is all that good news already priced in?
By
Bernhard Warner
November 16, 2020
Health
The science behind the leading COVID vaccine candidates
By
Sy Mukherjee
November 4, 2020
Newsletters
Not even Big Tech can save investors from the latest markets plunge
By
Bernhard Warner
October 28, 2020
Newsletters
Here’s what could happen to your portfolio in the case of a ‘no deal’ on fiscal stimulus
By
Bernhard Warner
October 21, 2020
Health
As COVID-19 numbers boom and markets tank, Europe’s leaders urge vaccine coordination
By
David Meyer
October 15, 2020
Health
J&J CEO still optimistic COVID-19 vaccine could come as early as this year
By
Robert Hackett
October 14, 2020
Newsletters
Investors pull back on vaccine jitters and earnings woes
By
Bernhard Warner
October 14, 2020
Newsletters
Earnings season is here. Will companies deliver on the hype?
By
Bernhard Warner
October 13, 2020
Health
J&J pauses COVID-19 vaccine trial after participant falls ill
By
Bloomberg
October 13, 2020
Health
Which COVID-19 vaccine works best? A new lab network promises an answer
By
Jeremy Kahn
October 6, 2020
Conferences
How 3 of biopharma’s most powerful women are building public trust during COVID
By
Sy Mukherjee
September 29, 2020
Most Popular
Success
Red Lobster’s 36-year-old CEO got the company out of bankruptcy. Now he’s plotting the ‘greatest comeback in the...
By
Sydney Lake
Success
Nvidia’s CEO Jensen Huang says electricians and plumbers will be needed by the hundreds of thousands in the new working...
By
Preston Fore
Law
Single mother sues — and beats — Kentucky for kicking her off food stamps because she bought food at the store where...
By
Sylvia Goodman
and
The Associated Press